Device/Diagnostics Quarterly Deal Statistics, Q1 2013
A look at financing, M&A, and alliance activity, January–March 2013
Executive Summary
Device companies kicked off 2013 by raising $1.1 billion via 45 transactions; the only device M&A transaction in Q1 to exceed the billion-dollar mark was Cardinal Health Inc.’s $2.07 billion acquisition of AssuraMed. Diagnostics firms began 2013 by raising a total of $286 million in the opening quarter, a 46% improvement over Q4 2012’s tally.
You may also be interested in...
Illumina Stakes A Claim In NIPT Market With $450-Million Acquisition Of Verinata
Gene-sequencing company Illumina has signed a definitive agreement to acquire Verinata Health for up to $450 million, staking its claim in the fast-growing, noninvasive prenatal genetic-testing market.
Stryker Enters China Race With Trauson Bid
The race to acquire a local foothold in China’s medical device industry is on. Stryker's bid to pay $764 million for Trauson Holdings would take out China’s second sizable domestic supplier of orthopedic implants.
Deerfield Management Opts For More Private Investment And A New Public Face
Deerfield Management, the $3.5 billion health care hedge fund, is aggressively expanding its investments in private life sciences companies. As many VCs continue to struggle raising new funds Deerfield hopes its shift, combined with a flexible, research-driven approach to investing and a new involvement in the civic and academic activities shaping the sector, will secure its position as a top health care financier.